Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy

A trial to evaluate the safety and immunogenicity of recombinant modified vaccinia Ankara (MVA) and fowlpox (FP) vectors expressing multiple HIV-1 proteins was conducted in twenty HIV-1 infected youth with suppressed viral replication on HAART. The MVA and FP-based multigene HIV-1 vaccines were safe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Greenough, Thomas C., Cunningham, Coleen K., Muresan, Petronella, McManus, Margaret, Persaud, Deborah, Fenton, Terry, Barker, Piers, Gaur, Aditya, Panicali, Dennis, Sullivan, John L., Luzuriaga, Katherine
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2845914/
https://ncbi.nlm.nih.gov/pubmed/18940219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.09.084
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars